Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.02 USD | -3.69% | -6.44% | +134.20% |
Jun. 12 | Vera Therapeutics, Inc. Appoints Christy Oliger to the Board | CI |
May. 28 | Vera Therapeutics Gets FDA Breakthrough Therapy Designation for Immunoglobulin A Nephropathy Treatment | MT |
Business Summary
Number of employees: 55
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Sean Grant
DFI | Director of Finance/CFO | 39 | 21-07-11 |
Kerry Cooper
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-03 |
Tom Doan
COO | Chief Operating Officer | 52 | 20-02-29 |
Chief Tech/Sci/R&D Officer | 56 | 23-01-07 | |
Julien Capers
LAW | General Counsel | - | 22-08-31 |
Joseph Young
AUD | Comptroller/Controller/Auditor | 52 | 21-02-28 |
Lauren Frenz
PRN | Corporate Officer/Principal | 39 | 20-03-31 |
Kelly Rauber
HRO | Human Resources Officer | - | 22-09-30 |
Corporate Officer/Principal | 58 | 23-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 16-05-31 |
Chairman | 63 | 22-05-23 | |
Patrick Enright
BRD | Director/Board Member | 62 | 20-10-31 |
Maha Katabi
BRD | Director/Board Member | 50 | 20-09-30 |
Andrew Cheng
BRD | Director/Board Member | 57 | 17-04-30 |
Scott Morrison
BRD | Director/Board Member | 66 | 20-03-31 |
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Kimball Hall
BRD | Director/Board Member | 58 | 21-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,701,217 | 50,371,395 ( 92.08 %) | 0 | 92.08 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+134.20% | 1.97B | |
+40.80% | 53.67B | |
-8.05% | 38.76B | |
+35.79% | 38.86B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- VERA Stock
- Company Vera Therapeutics, Inc.